Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial-Reference-Cited by-同舟云学术

Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial

Published:2020-03 Issue:4 Volume:106 Page:715-724
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Murray Julia R.,Tree Alison C.,Alexander Emma J.,Sohaib Aslam,Hazell Steve,Thomas Karen,Gunapala Ranga,Parker Chris C.,Huddart Robert A.,Gao Annie,Truelove Lesley,McNair Helen A.,Blasiak-Wal Irena,deSouza Nandita M.,Dearnaley David

Funder

National Institute for Health Research

Royal Marsden NHS Foundation Trust

The Institute of Cancer Research

CRUK

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference42 articles.

1. A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer;Wolff;Eur J Cancer,2015

2. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: Long-term results from the MRC RT01 randomised controlled trial;Dearnaley;Lancet Oncol,2014